APO RESEARCH · REPORT
Serum-Free Freezing Media
Freezing media which contain sera have the disadvantage of a fluctuating and not defined composition. Reproducibility of experiments with cells which were stored in a serum containing medium, could be affected by the usage of a different charge of the corresponding medium, since the composition of serum varies from batch to batch and only a limited amount of each batch is available.
Product & engineering
Understand the product.
Freezing media which contain sera have the disadvantage of a fluctuating and not defined composition. Reproducibility of experiments with cells which were stored in a serum containing medium, could be affected by the usage of a different charge of the corresponding medium, since the composition of serum varies from batch to batch and only a limited amount of each batch is available.
Selected research
Industry Research
Serum-Free Freezing Media Industry Research Report 2026
Market perspective
Freezing media which contain sera have the disadvantage of a fluctuating and not defined composition. Reproducibility of experiments with cells which were stored in a serum containing medium, could be affected by the usage of a different charge of the corresponding medium, since the composition of serum varies from batch to batch and only a limited amount of each batch is available.
Global Serum-Free Freezing Media key players include Thermo Fisher, Merck, Zenoaq, STEMCELL, etc. Global top four manufacturers hold a share over 70%.
North America is the largest market, with a share over 40%, followed by China, and Europe, both have a share over 35 percent.
Read the full market overview
In terms of product, With DMSO is the largest segment, with a share over 90%. And in terms of application, the largest application is Academic & Research Institutes, followed by Pharmaceutical & Biotechnology Companies.
Report Scope
This report quantifies the global Serum-Free Freezing Media market in terms of revenue (US$ million) and, where applicable, sales volume (K Liters), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Liters) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Serum-Free Freezing Media Market by Company
Thermo Fisher
Merck
Zenoaq
STEMCELL
GE Healthcare
BioLifeSolutions
Bio-Techne
Lonza
Biological Industries
Nippon Genetics
HiMedia
PromoCell
Serum-Free Freezing Media Segment by Type
With DMSO
DMSO-free
Serum-Free Freezing Media Segment by Application
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Serum-Free Freezing Media Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Serum-Free Freezing Media market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Serum-Free Freezing Media and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Serum-Free Freezing Media.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Serum-Free Freezing Media manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Serum-Free Freezing Media by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Serum-Free Freezing Media in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- With DMSO
- DMSO-free
Applications
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
Companies covered
- Thermo Fisher
- Merck
- Zenoaq
- STEMCELL
- GE Healthcare
- BioLifeSolutions
- Bio-Techne
- Lonza
- Biological Industries
- Nippon Genetics
- HiMedia
- PromoCell
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Serum-Free Freezing Media Market Size (2021-2032)
- 2.2.2 Global Serum-Free Freezing Media Sales (2021-2032)
- 2.2.3 Global Serum-Free Freezing Media Market Average Price (2021-2032)
- 2.3 Serum-Free Freezing Media by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 With DMSO
- 2.3.3 DMSO-free
- 2.4 Serum-Free Freezing Media by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Academic & Research Institutes
- 2.4.3 Pharmaceutical & Biotechnology Companies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Serum-Free Freezing Media Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Serum-Free Freezing Media Sales (K Liters) of Manufacturers (2021-2026)
- 3.3 Global Serum-Free Freezing Media Revenue of Manufacturers (2021-2026)
- 3.4 Global Serum-Free Freezing Media Average Price by Manufacturers (2021-2026)
- 3.5 Global Serum-Free Freezing Media Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Serum-Free Freezing Media, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Serum-Free Freezing Media, Product Type & Application
- 3.8 Global Manufacturers of Serum-Free Freezing Media, Established Date
- 3.9 Global Serum-Free Freezing Media Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Thermo Fisher
- 4.1.1 Thermo Fisher Company Information
- 4.1.2 Thermo Fisher Business Overview
- 4.1.3 Thermo Fisher Serum-Free Freezing Media Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Thermo Fisher Serum-Free Freezing Media Product Portfolio
- 4.1.5 Thermo Fisher Recent Developments
- 4.2 Merck
- 4.2.1 Merck Company Information
- 4.2.2 Merck Business Overview
- 4.2.3 Merck Serum-Free Freezing Media Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Merck Serum-Free Freezing Media Product Portfolio
- 4.2.5 Merck Recent Developments
- 4.3 Zenoaq
- 4.3.1 Zenoaq Company Information
- 4.3.2 Zenoaq Business Overview
- 4.3.3 Zenoaq Serum-Free Freezing Media Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Zenoaq Serum-Free Freezing Media Product Portfolio
- 4.3.5 Zenoaq Recent Developments
- 4.4 STEMCELL
- 4.4.1 STEMCELL Company Information
- 4.4.2 STEMCELL Business Overview
- 4.4.3 STEMCELL Serum-Free Freezing Media Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 STEMCELL Serum-Free Freezing Media Product Portfolio
- 4.4.5 STEMCELL Recent Developments
- 4.5 GE Healthcare
- 4.5.1 GE Healthcare Company Information
- 4.5.2 GE Healthcare Business Overview
- 4.5.3 GE Healthcare Serum-Free Freezing Media Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 GE Healthcare Serum-Free Freezing Media Product Portfolio
- 4.5.5 GE Healthcare Recent Developments
- 4.6 BioLifeSolutions
- 4.6.1 BioLifeSolutions Company Information
- 4.6.2 BioLifeSolutions Business Overview
- 4.6.3 BioLifeSolutions Serum-Free Freezing Media Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 BioLifeSolutions Serum-Free Freezing Media Product Portfolio
- 4.6.5 BioLifeSolutions Recent Developments
- 4.7 Bio-Techne
- 4.7.1 Bio-Techne Company Information
- 4.7.2 Bio-Techne Business Overview
- 4.7.3 Bio-Techne Serum-Free Freezing Media Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bio-Techne Serum-Free Freezing Media Product Portfolio
- 4.7.5 Bio-Techne Recent Developments
- 4.8 Lonza
- 4.8.1 Lonza Company Information
- 4.8.2 Lonza Business Overview
- 4.8.3 Lonza Serum-Free Freezing Media Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Lonza Serum-Free Freezing Media Product Portfolio
- 4.8.5 Lonza Recent Developments
- 4.9 Biological Industries
- 4.9.1 Biological Industries Company Information
- 4.9.2 Biological Industries Business Overview
- 4.9.3 Biological Industries Serum-Free Freezing Media Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Biological Industries Serum-Free Freezing Media Product Portfolio
- 4.9.5 Biological Industries Recent Developments
- 4.10 Nippon Genetics
- 4.10.1 Nippon Genetics Company Information
- 4.10.2 Nippon Genetics Business Overview
- 4.10.3 Nippon Genetics Serum-Free Freezing Media Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Nippon Genetics Serum-Free Freezing Media Product Portfolio
- 4.10.5 Nippon Genetics Recent Developments
- 4.11 HiMedia
- 4.11.1 HiMedia Company Information
- 4.11.2 HiMedia Business Overview
- 4.11.3 HiMedia Serum-Free Freezing Media Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 HiMedia Serum-Free Freezing Media Product Portfolio
- 4.11.5 HiMedia Recent Developments
- 4.12 PromoCell
- 4.12.1 PromoCell Company Information
- 4.12.2 PromoCell Business Overview
- 4.12.3 PromoCell Serum-Free Freezing Media Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 PromoCell Serum-Free Freezing Media Product Portfolio
- 4.12.5 PromoCell Recent Developments
5 Global Serum-Free Freezing Media Market Scenario by Region
- 5.1 Global Serum-Free Freezing Media Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Serum-Free Freezing Media Sales by Region: 2021-2032
- 5.2.1 Global Serum-Free Freezing Media Sales by Region: 2021-2026
- 5.2.2 Global Serum-Free Freezing Media Sales by Region: 2027-2032
- 5.3 Global Serum-Free Freezing Media Revenue by Region: 2021-2032
- 5.3.1 Global Serum-Free Freezing Media Revenue by Region: 2021-2026
- 5.3.2 Global Serum-Free Freezing Media Revenue by Region: 2027-2032
- 5.4 North America Serum-Free Freezing Media Market Facts & Figures by Country
- 5.4.1 North America Serum-Free Freezing Media Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Serum-Free Freezing Media Sales by Country (2021-2032)
- 5.4.3 North America Serum-Free Freezing Media Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Serum-Free Freezing Media Market Facts & Figures by Country
- 5.5.1 Europe Serum-Free Freezing Media Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Serum-Free Freezing Media Sales by Country (2021-2032)
- 5.5.3 Europe Serum-Free Freezing Media Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Serum-Free Freezing Media Market Facts & Figures by Country
- 5.6.1 Asia Pacific Serum-Free Freezing Media Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Serum-Free Freezing Media Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Serum-Free Freezing Media Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Serum-Free Freezing Media Market Facts & Figures by Country
- 5.7.1 South America Serum-Free Freezing Media Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Serum-Free Freezing Media Sales by Country (2021-2032)
- 5.7.3 South America Serum-Free Freezing Media Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Serum-Free Freezing Media Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Serum-Free Freezing Media Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Serum-Free Freezing Media Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Serum-Free Freezing Media Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Serum-Free Freezing Media Sales by Type (2021-2032)
- 6.1.1 Global Serum-Free Freezing Media Sales by Type (2021-2032) & (K Liters)
- 6.1.2 Global Serum-Free Freezing Media Sales Market Share by Type (2021-2032)
- 6.2 Global Serum-Free Freezing Media Revenue by Type (2021-2032)
- 6.2.1 Global Serum-Free Freezing Media Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Serum-Free Freezing Media Revenue Market Share by Type (2021-2032)
- 6.3 Global Serum-Free Freezing Media Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Serum-Free Freezing Media Sales by Application (2021-2032)
- 7.1.1 Global Serum-Free Freezing Media Sales by Application (2021-2032) & (K Liters)
- 7.1.2 Global Serum-Free Freezing Media Sales Market Share by Application (2021-2032)
- 7.2 Global Serum-Free Freezing Media Revenue by Application (2021-2032)
- 7.2.1 Global Serum-Free Freezing Media Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Serum-Free Freezing Media Revenue Market Share by Application (2021-2032)
- 7.3 Global Serum-Free Freezing Media Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Serum-Free Freezing Media Value Chain Analysis
- 8.1.1 Serum-Free Freezing Media Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Serum-Free Freezing Media Production Mode & Process
- 8.2 Serum-Free Freezing Media Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Serum-Free Freezing Media Distributors
- 8.2.3 Serum-Free Freezing Media Customers
9 Global Serum-Free Freezing Media Analyzing Market Dynamics
- 9.1 Serum-Free Freezing Media Industry Trends
- 9.2 Serum-Free Freezing Media Industry Drivers
- 9.3 Serum-Free Freezing Media Industry Opportunities and Challenges
- 9.4 Serum-Free Freezing Media Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst